
Genomics of ASD: Pathways to Biological Convergence and Genetic Therapies – Request for Applications
Grants awarded through this request for applications (RFA) are intended to improve our understanding of the molecular and cellular consequences of genetic risk for ASD, and to provide a foundation for the development of new therapies. Special emphasis is placed on the use of scalable methods, especially as applied to genes that are suitable targets for genetic therapies.
There are three budget tracks, depending on the scope of the project: an Explorer track of up to $400,000 over a period of up to two (2) years; an Expansion track of up to $1,500,000 over a period of up to three (3) years; and a Collaboration track of up to $750,000 per lab over a period of up to three (3) years. All budget figures are inclusive of 20 percent indirect costs.